Clinical Trial Update: A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is [Phase 2]

View source ↗

Summary

Phase 2 trial assessing longer-term tolerability and efficacy of BI 730357 in plaque psoriasis; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BI 730357

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Psoriasis | Phase 2 | Status: TERMINATED | Results posted: 2022-11-18